Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients

NCT05324332 ·Status: RECRUITING ·Phase: NA

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

NCT05799248 ·Status: RECRUITING ·Phase: PHASE3

Study of Diagnostic Performance of [18F]CTT1057 in BCR

NCT04838613 ·Status: COMPLETED ·Phase: PHASE3

Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.

NCT06922903 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

NCT02077335 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

NCT06754085 ·Status: RECRUITING ·Phase: PHASE3

Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR

NCT03149861 ·Status: COMPLETED ·Phase: NA

Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer

NCT03451812 ·Status: UNKNOWN

Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients

NCT06262139 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients

NCT02623933 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients

NCT06723665 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

NCT04243941 ·Status: WITHDRAWN ·Phase: PHASE2

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

NCT05676463 ·Status: TERMINATED ·Phase: PHASE2

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

NCT03392181 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

NCT02981368 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis

NCT06756334 ·Status: RECRUITING ·Phase: EARLY_PHASE1

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

NCT05852041 ·Status: RECRUITING ·Phase: EARLY_PHASE1

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

NCT06901492 ·Status: NOT_YET_RECRUITING ·Phase: NA

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

NCT05010343 ·Status: RECRUITING ·Phase: PHASE2

18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study

NCT05707182 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor

NCT05761366 ·Status: RECRUITING ·Phase: PHASE2

Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

NCT06575361 ·Status: COMPLETED ·Phase: NA

Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment

NCT07011342 ·Status: RECRUITING ·Phase: NA

Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis

NCT05004285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients

NCT05847348 ·Status: RECRUITING ·Phase: PHASE3